The intrepid Ed Silverman has again taken a well-deserved day off, and it's me, Chris Truelove, director of content for Pharmalive, here once again taking his place. My cup of stimulation today is once again Wawa's variety of hazelnut coffee. It's been a pretty quiet week as it's the summer, and I suspect a lot of people will be watching the Summer Olympic opening ceremonies from London this evening. If the Olympics aren't your bag, I hope you have nice plans to start off the weekend. Here are a few headlines to ponder on in the meanwhile:
Merck Profit Tops Estimates as Sales of Diabetes Drugs Grow (Bloomberg)
Two More Men with HIV now Virus-Free. Is This a Cure? (NBCnews.com)
Late Shift Linked to Heart Risk; USFDA Pulls 'Meatless' Memo (USA Today)
Hot, Dry Weather Heightens West Nile Virus Risk (CBSNews.com)
Case of Suspect in NH Hepatitis Outbreak 'Has Tentacles All Over the Country' (Bangor Daily News)
Five Infant Deaths Signal Serious UK Whooping Cough Outbreak (The Guardian)
Amarin Falls After U.S. Approval Limits Debut Drug's Use (Bloomberg)
FDA Recommends Drug to Treat Diabetics' Vision Loss (Reuters)